Calithera Biosciences, Inc. | S-8 POS | 0001193125-23-070145

SEC Filing Details

Document Details

Form

Filing Date

Mar 14, 2023

Document Date

Mar 14, 2023

Form Description

Post-effective amendment to an S-8 filing

Filing Group

Registration Statements

Company

Calithera Biosciences, Inc.

Issuer

Calithera Biosciences, Inc.

Filing Formats

View HTML

Download PDF

Download DOC

Investor & Media Contact

Stephanie Wong
Chief Financial Officer

1.650.870.1063
ir@Calithera.com

Investor Tools